2014
DOI: 10.1074/jbc.r114.609248
|View full text |Cite
|
Sign up to set email alerts
|

Multidrug Resistance Protein 1 (MRP1, ABCC1), a “Multitasking” ATP-binding Cassette (ABC) Transporter

Abstract: The multidrug resistance protein 1 (MRP1) encoded by ABCC1 was originally discovered as a cause of multidrug resistance in tumor cells. However, it is now clear that MRP1 serves a broader role than simply mediating the ATP-dependent efflux of drugs from cells. The antioxidant GSH and the pro-inflammatory cysteinyl leukotriene C 4 have been identified as key physiological organic anions effluxed by MRP1, and an ever growing body of evidence indicates that additional lipid-derived mediators are also substrates o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
270
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 300 publications
(273 citation statements)
references
References 100 publications
(124 reference statements)
1
270
0
2
Order By: Relevance
“…ABC transporters are found in all organisms and have a wide range of endogenous and exogenous substrates. Among the ABC family are the multifunctional 'multidrug resistance' (MDR) transporters of the ABCB, -C, and -G subfamilies, which have primarily been studied for their xenobiotic efflux, because their overexpression in cancer cells leads to drug resistance (Szakacs et al, 2006;Chen and Tiwari, 2011;Cole, 2014). However, in addition to effluxing drugs, these transporters can also contribute to disease by moving signaling molecules that govern morphogenetic behaviors of cells (Fletcher et al, 2010;Henderson et al, 2011;Jin et al, 2014;van de Ven et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…ABC transporters are found in all organisms and have a wide range of endogenous and exogenous substrates. Among the ABC family are the multifunctional 'multidrug resistance' (MDR) transporters of the ABCB, -C, and -G subfamilies, which have primarily been studied for their xenobiotic efflux, because their overexpression in cancer cells leads to drug resistance (Szakacs et al, 2006;Chen and Tiwari, 2011;Cole, 2014). However, in addition to effluxing drugs, these transporters can also contribute to disease by moving signaling molecules that govern morphogenetic behaviors of cells (Fletcher et al, 2010;Henderson et al, 2011;Jin et al, 2014;van de Ven et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…In addition to its role in drug resistance, MRP1 is important for the transport of physiologic substrates, including mediators of inflammation such as leukotriene C 4 (LTC 4 ) and the cholestatic steroid 17b-estradiol 17-(b-D-glucuronide) (E 2 17bG) (Cole, 2014a). Furthermore, MRP1 transports a variety of other drugs, toxicants, and carcinogens often conjugated to GSH, glucuronate, or sulfate (Jedlitschky et al, 1996;Leslie et al, 2005;Loe et al, 1996a,b).…”
Section: Introductionmentioning
confidence: 99%
“…The scarcity of specific MRP1 inhibitors reflects the fact that there is still no clarity about the benefit of P-gp inhibition in the clinical practice, which retards research efforts to develop MRP1 inhibitors for clinical use [190] . However, the calcium channel blocker verapamil and its derivative NMeOHI2, in addition to the several non-steroidal anti-inflammatory drugs (e.g., indomethacin), have shown collateral sensitivity toward MRP1 overexpressing cells [191,192] .…”
Section: Examples Of Such Inhibitors Are Cyclosporine a [26184-187]mentioning
confidence: 99%